Erik Bischoff

1.5k total citations
57 papers, 681 citations indexed

About

Erik Bischoff is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and General Health Professions. According to data from OpenAlex, Erik Bischoff has authored 57 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 24 papers in Epidemiology and 20 papers in General Health Professions. Recurrent topics in Erik Bischoff's work include Chronic Disease Management Strategies (23 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (22 papers) and Asthma and respiratory diseases (13 papers). Erik Bischoff is often cited by papers focused on Chronic Disease Management Strategies (23 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (22 papers) and Asthma and respiratory diseases (13 papers). Erik Bischoff collaborates with scholars based in Netherlands, United States and Singapore. Erik Bischoff's co-authors include Tjard Schermer, Chris van Weel, Jean Bourbeau, Lisette van den Bemt, Maria Sedeno, Andrea Benedetti, François Maltais, Sarah Bernard, Henk Schers and Hans Bor and has published in prestigious journals such as PLoS ONE, Scientific Reports and BMJ.

In The Last Decade

Erik Bischoff

46 papers receiving 667 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erik Bischoff Netherlands 16 352 172 153 142 90 57 681
Ivo Smeele Netherlands 19 464 1.3× 300 1.7× 163 1.1× 366 2.6× 131 1.5× 46 937
Germano Bettoncelli Italy 16 658 1.9× 53 0.3× 143 0.9× 458 3.2× 60 0.7× 38 916
Victor A. Kiri United Kingdom 19 822 2.3× 106 0.6× 125 0.8× 466 3.3× 70 0.8× 39 1.4k
Matthew B. Stanbrook Canada 20 748 2.1× 83 0.5× 128 0.8× 501 3.5× 109 1.2× 69 1.2k
Deborah Burton Australia 15 379 1.1× 124 0.7× 53 0.3× 345 2.4× 107 1.2× 31 776
Daryl Freeman United Kingdom 17 1.2k 3.3× 71 0.4× 81 0.5× 786 5.5× 97 1.1× 39 1.4k
R Beveridge United Kingdom 5 434 1.2× 164 1.0× 98 0.6× 509 3.6× 89 1.0× 6 944
Ann-Christin Jonsson Sweden 9 1.0k 2.9× 72 0.4× 89 0.6× 635 4.5× 85 0.9× 9 1.2k
Elisabeth Ståhl Sweden 18 1.3k 3.7× 222 1.3× 96 0.6× 1.1k 7.7× 79 0.9× 28 1.8k
Prakash Navaratnam United States 15 258 0.7× 121 0.7× 48 0.3× 348 2.5× 38 0.4× 65 736

Countries citing papers authored by Erik Bischoff

Since Specialization
Citations

This map shows the geographic impact of Erik Bischoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Bischoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Bischoff more than expected).

Fields of papers citing papers by Erik Bischoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Bischoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Bischoff. The network helps show where Erik Bischoff may publish in the future.

Co-authorship network of co-authors of Erik Bischoff

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Bischoff. A scholar is included among the top collaborators of Erik Bischoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Bischoff. Erik Bischoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bemt, Lisette van den, Bram van den Borst, Michel M. van den Heuvel, et al.. (2025). Developing an interprofessional collaboration for COPD patients in primary care: a participatory action research approach. npj Primary Care Respiratory Medicine. 35(1). 43–43.
3.
Bischoff, Erik, Job F. M. van Boven, Job van der Palen, et al.. (2025). Adherence to Inhaled Medication Guidelines in Patients with COPD: Evaluating the GOLD 2023 Strategy in a Real-World Secondary Care Setting. International Journal of COPD. Volume 20. 3877–3891.
4.
Bemt, Lisette van den, et al.. (2025). De-implementation of inappropriate inhaled corticosteroid use in patients with COPD in general practice, results of a mixed methods study. npj Primary Care Respiratory Medicine. 35(1). 44–44.
5.
Dulmen, Simone A. van, et al.. (2024). Policy Versus Practice: Facilitators and Barriers of Chronic Care Integration in Dutch General Practice – a Survey Study. International Journal of Integrated Care. 24(4). 13–13.
6.
Mastebroek, Mathilde, et al.. (2024). Asthma and COPD management of patients with intellectual disabilities in general practice. npj Primary Care Respiratory Medicine. 34(1). 15–15. 1 indexed citations
7.
Bischoff, Erik, et al.. (2023). Effects of Adherence to an mHealth Tool for Self-Management of COPD Exacerbations. International Journal of COPD. Volume 18. 2381–2389.
8.
Cuypers, Maarten, et al.. (2023). Chronic disease management in patients with intellectual disabilities: a matched study in Dutch general practice. British Journal of General Practice. 73(735). e744–e751. 2 indexed citations
10.
Bischoff, Erik, Ruud L.M. Bekkers, Inge M.C.M. de Kok, et al.. (2023). Acceptability of risk-based triage in cervical cancer screening: A focus group study. PLoS ONE. 18(8). e0289647–e0289647. 5 indexed citations
11.
Cuypers, Maarten, et al.. (2021). Exploring chronic disease prevalence in people with intellectual disabilities in primary care settings: A scoping review. Journal of Applied Research in Intellectual Disabilities. 35(2). 382–398. 11 indexed citations
13.
Stella, Fabio, et al.. (2019). A comparison between discrete and continuous time Bayesian networks in learning from clinical time series data with irregularity. Artificial Intelligence in Medicine. 95. 104–117. 21 indexed citations
14.
Bischoff, Erik, Peter Lucas, Reinier Akkermans, et al.. (2019). A Smart Mobile Health Tool Versus a Paper Action Plan to Support Self-Management of Chronic Obstructive Pulmonary Disease Exacerbations: Randomized Controlled Trial. JMIR mhealth and uhealth. 7(10). e14408–e14408. 36 indexed citations
15.
Bischoff, Erik, Jan H. Vercoulen, Reinier P. Akkermans, et al.. (2018). 'Exacerbation-free time' to assess the impact of exacerbations in patients with chronic obstructive pulmonary disease (COPD): a prospective observational study. npj Primary Care Respiratory Medicine. 28(1). 12–12. 14 indexed citations
17.
Bemt, Lisette van den, et al.. (2011). Multidimensional prognostic indices for use in COPD patient care. A systematic review. Respiratory Research. 12(1). 151–151. 64 indexed citations
18.
Bischoff, Erik, Maria Sedeno, Andrea Benedetti, et al.. (2010). Effects of written action plan adherence on COPD exacerbation recovery. Thorax. 66(1). 26–31. 116 indexed citations
19.
Bischoff, Erik, et al.. (2010). Dynamic hyperinflation after metronome-paced hyperventilation in COPD– A 2 year follow-up. Respiratory Medicine. 104(11). 1700–1705. 12 indexed citations
20.
Bischoff, Erik, et al.. (2009). Trends in COPD prevalence and exacerbation rates in Dutch primary care. British Journal of General Practice. 59(569). 927–933. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026